Welcome to experience our exciting mariPOC® booth #100 in ECCMID 2018, Madrid, Spain, April 21th – 24th!
Main topics at ArcDia’s booth:
The new mariPOC CDI test – Scientific presentation at the booth.
Dr. Savolainen from Vaasa Central Hospital presents the brand new mariPOC C. difficile evaluation study results on Monday April 23rd at 13.30-14.00.
The study is also published as a poster (number 2273) Prospective evaluation of mariPOC test for the detection of Clostridium difficile infection (abstract number 5333).
Welcome to discuss with Dr. Savolainen and our mariPOC experts about the new automated C. difficile test – the most efficient solution to meet with the new ESCMID guideline for CDI testing!
Phenotypic mariAST outperforms PCR in sensitivity
ArcDia’s launches the first AST application mariAST MRSA (RUO).
Scientific results suggest that mariAST MRSA reaches the sensitivity of 1 CFU thus outperforming PCR in sensitivity.
Antikainen et al. (2017). 27th ECCMID. Abstract #4771 and poster #P0172.
ArcDia expands in Latin Americas
Inversiones Naturalia, Mepatek (www.medicapanamadetecnologia.com), the mariPOC representative in Latin America is present at ArcDia’s booth #100. Bienvenidos a conocernos!
Representantes de mariPOC en America Latina, Inversiones Naturalia, Mepatek (www.medicapanamadetecnologia.com), esta presente en el estand ArcDia numero 100. Bienvenidos a conocernos!